NexgenRx Inc.
NEGXF
$0.1964
$0.00492.56%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -3.22% | 11.31% | |||
| Total Other Revenue | 46.15% | 51.29% | |||
| Total Revenue | -0.93% | 12.69% | |||
| Cost of Revenue | -12.08% | 59.35% | |||
| Gross Profit | 1.92% | 4.84% | |||
| SG&A Expenses | 8.95% | 3.92% | |||
| Depreciation & Amortization | 6.67% | -3.01% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.90% | 12.34% | |||
| Operating Income | -36.05% | 15.22% | |||
| Income Before Tax | -31.99% | 8.56% | |||
| Income Tax Expenses | -3.77% | -104.63% | |||
| Earnings from Continuing Operations | -30.44% | 1,964.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -30.44% | 1,964.47% | |||
| EBIT | -36.05% | 15.22% | |||
| EBITDA | -17.53% | 56.91% | |||
| EPS Basic | -25.00% | 308.70% | |||
| Normalized Basic EPS | -38.71% | 6.90% | |||
| EPS Diluted | -14.29% | 275.00% | |||
| Normalized Diluted EPS | -41.38% | 0.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.92% | |||
| Average Diluted Shares Outstanding | 0.26% | 8.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 16.56% | 1.02% | |||